The NESPONE brand, founded in 1999 (United States), from
142 sister brands
and 17478 competing brands.
NESPONE is owned by Amgen, listed on the stock exchange of New York
NESPONE is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.